Susquehanna International Group
GSK icon

Susquehanna International Group’s GSK GSK Stock Holding History

Susquehanna International Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5M Buy
444,000
+40,600
+10% +$2.2M ﹤0.01% 1966
2025
Q4 		$19.8M Sell
403,400
-241,900
-37% -$11.3M ﹤0.01% 2220
2025
Q3 		$27.9M Sell
645,300
-103,500
-14% -$4.04M ﹤0.01% 1867
2025
Q2 		$28.8M Buy
748,800
+218,000
+41% +$8.33M ﹤0.01% 1646
2025
Q1 		$20.6M Buy
530,800
+71,100
+15% +$2.6M ﹤0.01% 1720
2024
Q4 		$15.5M Buy
459,700
+60,000
+15% +$2.16M ﹤0.01% 2115
2024
Q3 		$16.3M Sell
399,700
-134,800
-25% -$5.51M ﹤0.01% 2035
2024
Q2 		$20.6M Buy
534,500
+80,500
+18% +$3.39M ﹤0.01% 1692
2024
Q1 		$19.5M Sell
454,000
-141,100
-24% -$5.82M ﹤0.01% 1804
2023
Q4 		$22.1M Sell
595,100
-184,200
-24% -$6.61M ﹤0.01% 1705
2023
Q3 		$28.2M Sell
779,300
-245,600
-24% -$8.72M 0.01% 1434
2023
Q2 		$36.5M Sell
1,024,900
-24,500
-2% -$879K 0.01% 1212
2023
Q1 		$37.3M Buy
1,049,400
+103,000
+11% +$3.6M 0.01% 1144
2022
Q4 		$33.3M Sell
946,400
-201,000
-18% -$6.7M 0.01% 1133
2022
Q3 		$33.8M Buy
1,147,400
+832,440
+264% +$31.5M 0.01% 1044
2022
Q2 		$17.1M Sell
314,960
-106,320
-25% -$5.87M ﹤0.01% 1586
2022
Q1 		$22.9M Sell
421,280
-168,240
-29% -$9.14M ﹤0.01% 1600
2021
Q4 		$32.5M Sell
589,520
-229,200
-28% -$11.9M ﹤0.01% 1411
2021
Q3 		$39.1M Sell
818,720
-83,280
-9% -$4.18M 0.01% 1338
2021
Q2 		$44.9M Sell
902,000
-281,280
-24% -$13.5M 0.01% 1271
2021
Q1 		$52.8M Sell
1,183,280
-107,920
-8% -$4.9M 0.01% 1059
2020
Q4 		$59.4M Buy
1,291,200
+607,120
+89% +$27.9M 0.01% 910
2020
Q3 		$32.2M Sell
684,080
-59,840
-8% -$3M 0.01% 1132
2020
Q2 		$37.9M Buy
743,920
+213,360
+40% +$10.9M 0.01% 979
2020
Q1 		$25.1M Sell
530,560
-413,840
-44% -$22.1M 0.01% 1042
2019
Q4 		$55.5M Sell
944,400
-148,880
-14% -$8.28M 0.02% 753
2019
Q3 		$58.3M Buy
1,093,280
+315,680
+41% +$16.2M 0.02% 660
2019
Q2 		$38.9M Buy
777,600
+209,360
+37% +$10.5M 0.01% 821
2019
Q1 		$29.7M Sell
568,240
-126,800
-18% -$6.34M 0.01% 923
2018
Q4 		$33.2M Buy
695,040
+168,000
+32% +$8.27M 0.01% 776
2018
Q3 		$26.5M Sell
527,040
-59,440
-10% -$3.02M 0.01% 1111
2018
Q2 		$29.6M Sell
586,480
-885,120
-60% -$44.6M 0.01% 1003
2018
Q1 		$71.9M Buy
1,471,600
+323,120
+28% +$15M 0.03% 510
2017
Q4 		$50.9M Buy
1,148,480
+416,480
+57% +$19.2M 0.02% 683
2017
Q3 		$37.1M Buy
732,000
+179,280
+32% +$9.1M 0.01% 806
2017
Q2 		$29.8M Sell
552,720
-183,360
-25% -$9.77M 0.01% 878
2017
Q1 		$38.8M Sell
736,080
-426,480
-37% -$21.6M 0.02% 681
2016
Q4 		$56M Buy
1,162,560
+148,640
+15% +$7.34M 0.03% 519
2016
Q3 		$54.7M Buy
1,013,920
+189,120
+23% +$10.4M 0.03% 519
2016
Q2 		$44.7M Sell
824,800
-53,680
-6% -$2.83M 0.02% 552
2016
Q1 		$44.5M Sell
878,480
-125,120
-12% -$6.23M 0.02% 570
2015
Q4 		$50.6M Sell
1,003,600
-404,800
-29% -$20.6M 0.02% 597
2015
Q3 		$67.7M Buy
1,408,400
+30,000
+2% +$1.56M 0.03% 494
2015
Q2 		$71.8M Buy
1,378,400
+279,760
+25% +$15.8M 0.03% 515
2015
Q1 		$63.4M Sell
1,098,640
-71,760
-6% -$4.11M 0.03% 533
2014
Q4 		$62.5M Sell
1,170,400
-85,440
-7% -$4.78M 0.02% 614
2014
Q3 		$72.2M Buy
1,255,840
+795,120
+173% +$48.7M 0.03% 544
2014
Q2 		$30.8M Buy
460,720
+135,760
+42% +$9.19M 0.01% 1038
2014
Q1 		$21.7M Buy
324,960
+7,840
+2% +$530K 0.01% 1206
2013
Q4 		$21.2M Sell
317,120
-184,560
-37% -$12M 0.01% 1297
2013
Q3 		$31.5M Buy
501,680
+68,800
+16% +$4.43M 0.02% 881
2013
Q2 		$27M Buy
+432,880
New +$27.5M 0.02% 883

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group's GSK Position: Q1 2026 in Review

Susquehanna International Group increased its GSK (GSK) stake by 568% in Q1 2026, buying an estimated $2.65M and bringing the position to 57,448 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #5165.

Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since. The position peaked at $54.8M in Q4 2014. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Susquehanna International Group held 57,448 shares of GSK worth $3.17M as of Q1 2026.
  • Susquehanna International Group bought 48,853 GSK shares in Q1 2026, an estimated $2.65M.
  • GSK made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5165 holding.
  • Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's GSK position peaked at $54.8M in Q4 2014.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.